InsidersTradesSigma
Follow the Indoco Remedies Limited stock price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Indoco Remedies Limited has logged 62 reports. Market capitalisation: €20.2bn. The latest transaction was disclosed on 30 December 2025 (Purchase). Among the most active insiders: MADHURA SURESH KARE. All data is openly available.
62
Insider Decl.
n/a
Thresholds
€1m
54 ops.
Buy Volume
€438,848
8 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Indoco Remedies Limited Hold (neutral), based on 4 analysts. Average price target: ₹264.00.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,884 of 29,063 companies
34.3
score / 100
Value36
Quality33
FCF yld5.0%
Earn yld-4.7%
EV/EBITDA21.9x
ROE-10%
Gross mgn70%
Net mgn-5.3%
Debt/EBITDA7.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 December 2025
Declarations62 total
5,534,874 shares@ ₹2.0041.5% of flowEquity SharesSEBI:0f9a4ef39b890e1ed8e674d078f1e16f409782a8
5,534,874 shares@ ₹2.0034.2% of flowEquity SharesSEBI:b75196978389670011aa43a393621f7aab4d415c
2,767,437 shares@ ₹2.0042.4% of flowEquity SharesSEBI:0db8a2333583c00639cf3370048e684c56cdc06b
7,562,181 shares@ ₹2.0058.5% of flowEquity SharesSEBI:1388c0dcb8fd35f3c983626a18e5886e1b0b4e33
5,534,874 shares@ ₹2.0035.2% of flowEquity SharesSEBI:f939fe3ec64f80cd8f040fb367bf42e404b7d8e7
2,767,437 shares@ ₹2.0024.1% of flowEquity SharesSEBI:dcaf1fca00ce148b86e9ab9342ea692b86ee8732
4,794,714 shares@ ₹2.0030.5% of flowEquity SharesSEBI:194a60da5e9676dcffa30bffff385270f059e1d3
2,767,467 shares@ ₹2.00100.0% of flowEquity SharesSEBI:11cc35b4ea5a0f8eb9b202d3d3bb0ea325d5b594
7,800 shares@ ₹285.1078.5% of flowEquity SharesSEBI:7f892ef532407b7c267bedc9dea761cd6d62b7da
7,300 shares@ ₹299.089.6% of flowEquity SharesSEBI:c90f00a6cf58554a0fb69e58e7c5bf4c4c08e335
7,300 shares@ ₹286.6692.4% of flowEquity SharesSEBI:08ca0b7591cb5cbd649e21b1ea6276488138ebdf
13,000 shares@ ₹292.0685.4% of flowEquity SharesSEBI:bd6f89990582640556a941e7ba74ffefc22261cd
20,800 shares@ ₹294.3833.3% of flowEquity SharesSEBI:f5e3a56c1985fb79db30d5192eb49b8291f999ef
12,150 shares@ ₹229.590114.1% of flowEquity SharesSEBI:668a8fc2ee599178846fca80e2859317247e1f42
26,000 shares@ ₹218.741528.5% of flowEquity SharesSEBI:6fb739146a782a4a18aa823b293e99a084b5f7f1
2,600 shares@ ₹222.232.9% of flowEquity SharesSEBI:df24cdb4f85a7009549e9a8408e838aa0f0d7b4e
19,300 shares@ ₹231.036322.6% of flowEquity SharesSEBI:2e9e3a1624a0953a3cc2abbadc5758ea344c1bf7
8,153 shares@ ₹235.009.8% of flowEquity SharesSEBI:398437753e10fe33ec5a346e7f29b6f3eb2e0f6d
9,446 shares@ ₹224.486611.0% of flowEquity SharesSEBI:30911fde2392e38ec3cbca1fd0ba060655af9e47
9,401 shares@ ₹224.7911.1% of flowEquity SharesSEBI:e6760400c70763913b7a2174d8f2bd709fa74a87
10,000 shares@ ₹249.2512.3% of flowEquity SharesSEBI:cf9ba0eb96d0e7d55c9486b6a778d069de29d363
9,500 shares@ ₹259.8512.2% of flowEquity SharesSEBI:ce487528f20ee1dab3090a892b9af23486fe9d33
4,000 shares@ ₹251.02100.0% of flowEquity SharesSEBI:09be0a50b6752dc3e440f1020bc088bae060cd9c
9,250 shares@ ₹268.6212.2% of flowEquity SharesSEBI:9185f8b79a0e5910b8e16d7ede54f35c24981706
9,150 shares@ ₹270.5621.3% of flowEquity SharesSEBI:08d5439531fb7cb75d2afbfd06cb07685fc31245
25 of 62 declarations
关于 Indoco Remedies Limited
Indoco Remedies Limited 是一家印度制药公司，专注于仿制药和制剂的制造。该公司主要在印度市场运营，并将其产品出口到多个国家。